Bemærk: Kan ikke garanteres før jul. Se dato på varen.
Forventes på lager: 15-01-2026
This book focuses on current research and methodologies developed for re-engineering cancer clinical trials and also for "hot" areas in drug development trials such as adaptive design, seamless Phase 2-3 trials, and personalized medicine using biomarkers. Background statistical methodology is summarized in the Appendix.
| Forlag | Taylor & Francis Inc |
| Forfattere | Tze Leung (Stanford University Lai, Philip (Stanford University Lavori |
| Type | Bog |
| Format | Hardback |
| Sprog | Engelsk |
| Udgivelsesdato | 15-01-2026 |
| Første udgivelsesår | 2026 |
| Serie | Chapman & Hall/CRC Biostatistics Series |
| Illustrationer | 50 Illustrations, black and white |
| Originalsprog | United States |
| Sideantal | 300 |
| Indbinding | Hardback |
| Forlag | Taylor & Francis Inc |
| Sideoplysninger | 300 pages, 50 Illustrations, black and white |
| Mål | 234 x 156 |
| ISBN-13 / EAN-13 | 9781466514867 |